Newsroom | 5467 results

Sorted by: Latest
Optical
-

Vision Loss Takes an Emotional Toll. Hadley Is Addressing It.

WINNETKA, Ill.--(BUSINESS WIRE)--Hadley's free video series on the emotional impact of vision loss draws its strongest early response, pointing to a gap in vision care....
-

Credo Launches 800G ZeroFlap Optical Transceivers Engineered for AI Networks

SAN JOSE, Calif.--(BUSINESS WIRE)--Credo launches 800G ZeroFlap optical transceivers engineered for AI networks....
-

Aldeyra Therapeutics Receives Complete Response Letter from the U.S. Food and Drug Administration for the Reproxalap New Drug Application for the Treatment of Signs and Symptoms of Dry Eye Disease

LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced receipt of a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) for the New Drug Application (NDA) of reproxalap, an investigational drug candidate, for the treatment of dry eye disease. The CRL stated that there is “a lack of substantial...
-

Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement

GENEVA--(BUSINESS WIRE)--Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement...
-

Neurotech Provides Corporate Update on Commercial Progress

CUMBERLAND, R.I.--(BUSINESS WIRE)--Neurotech Pharmaceuticals, Inc. (the “Company”) today provided an update on its ongoing transition to a commercial‑stage company following the first anniversary of the FDA’s approval of ENCELTO™ (taroretcel-lwey), the Company’s encapsulated cell‑based gene therapy for adults with idiopathic Macular Telangiectasia Type 2 (MacTel). ENCELTO continues to be integrated into retina practices nationwide, supported by expanding access and established commercial manufa...
-

Johnson & Johnson Announces FDA Approval of TECNIS PureSee Intraocular Lens, a Breakthrough Solution for U.S. Cataract Patients

JACKSONVILLE, Fla.--(BUSINESS WIRE)--Johnson & Johnson Announces FDA Approval of TECNIS PureSee Intraocular Lens, a Breakthrough Solution for U.S. Cataract Patients...
-

Heru Showcases PretestPro™ for the Heru VR-Powered Diagnostic Headset at Vision Expo

MIAMI--(BUSINESS WIRE)--Heru, the leader in AI-powered vision diagnostics, announced it is showcasing the new PretestPro on its Heru wearable platform at Vision Expo 2026....
-

Aurion Biotech Appoints World Renowned Cornea Surgeon Marjan Farid, M.D., to Chair Medical Advisory Board

SEATTLE & CAMBRIDGE, Mass. & TOKYO--(BUSINESS WIRE)--Aurion Biotech, Inc. (“Aurion”), a commercial-stage regenerative cell therapy company dedicated to restoring vision and working toward a future where blindness is eliminated, today announced the appointment of Dr. Marjan Farid of the Gavin Herbert Eye Institute at the University of California-Irvine (UCI) as Chair of Aurion Biotech’s medical advisory board (MAB). Dr. Farid is a distinguished cornea, cataract and refractive surgeon, a global e...
-

Sightview Unveils Fresh Patient Engagement Tools at Vision Expo 2026

DURHAM, N,C.--(BUSINESS WIRE)--Sightview will showcase two recently updated tools for its eyecare-specific EHR/PM offering at Vision Expo 2026. See demos in booth #4021....
-

National Vision Announces Winners of 11th Annual Scholarship Program

DULUTH, Ga.--(BUSINESS WIRE)--National Vision Announces Winners of 11th Annual Scholarship Program...